Skip to content

Released May 14, 2014, after the close

10-Q filed May 14, 2014, 44 days after period end · 0001144204-14-030423

Q1 2014 · 10-Q
Revenue—
Net Income-$4.07MN/M vs Q1 2013N/M vs Q4 2013
EPS Diluted-$0.92N/M vs Q1 2013no prior Q4 2013 on file
Operating Income-$4,110,151N/M
Operating Cash Flow-$5,185,061N/M
Free Cash Flowderived-$5,187,650N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ1 2014Q1 2013Q1 2012Q1 2011
Net Income-$4.07M-$3.72M-$8.17M-$2.72M
EPS Diluted-$0.92-$0.22-$0.66-$0.38

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR